Manufacturing- Morepen Labs
The company has 3 state-of-the-art manufacturing plants in the
northern state of Himachal Pradesh (HP) in India. The main plant at Parwanoo is
Inspected and approved by United States Food and Drug Administration (USFDA)
for production of Loratadine, which is the best selling anti-allergy drug
globally. Morepen has developed a hi-tech Pharma Complex at Morepen Village,
Baddi (HP) on 60 acres of land that has various multipurpose pharma facilities
for API & finished dosages and a Research Centre. The plant is in process
of seeking an endorsement from US-FDA, UK-MCA, South Africa MCC and TGA
Australia. Another plant at Parwanoo is exclusively dedicated for manufacturing
finished dosage products.
Set amidst pristine pollution - free surroundings where clean air and nature
acts as the greatest purifier. The plants themselves are a marvel of proactive,
international design made to global specifications.
Morepen's Vision is to be a Global pharmaceutical player with
strong R&D support and internationally accredited plants in India for cost
effective generic products. The focus is primarily on the highly lucrative
pharma markets of US, Canada and Europe for hi value finished formulations for
which series of ANDA's would be filed. Morepen has resources of international
standing and manufacturing facilities adhering to the most stringent standards
of quality excellence.
The Bulk drug manufacturing facility is situated at Masulkhana,
Distt. Solan (Himachal Pradesh) which is about 40 km from Chandigarh.Facilities
for manufacturing meets the cGMP standards. This facility is approved by USFDA
for manufacturing of Loratadine.
The Formulation unit is situated at Parwanoo Distt. Solan (H.P.)
which is about 35 km from Chandigarh.
The manufacturing facilities includes latest GMP models of
equipments for making tablets, capsules and their packing.
MLL has extensive future plans for the manufacturing of
pharmaceuticals and OTC products, both for the domestic and international
marketing. In view of these expansion programs, 65 acres of land has been
acquired at Baddi, which is about 50 Kms from Chandigarh. State-of-the-art
facilities for Bulk Drugs, Dosage forms and FMHG products have been
established. The infrastructure has been developed in accordance with GMP
requirements of FDA with the help of GMP consultants from Pharmaplan, Germany.
Two big production blocks for bulk drug are in operation while third block
is is getting readied for operations.
The undiluted commitment to excellence in everything has won Morepen USFDA
approval for the manufacturing of Loratadine at its state-of-the-art plant at
Masulkhana at Parwanoo. Set amidst pristine pollution-free surroundings where
clean air and nature acts as the greatest purifier. The plants themselves are a
marvel of proactive, international design made to Global specifications,
stringent quality control systems and approvals.